Skip to main content
Caplight Logo









KroniKare

KroniKare

Private
SingaporeHealthcare & Life Scienceshttps://kronikare.com/

Last Round

Series A

Oct 6, 2020

Est. Valuation

$5.21M

Total Funding Raised

$2.06M

Company Overview

KroniKare is a healthtech company that provides an artificial intelligence-based technology for the assessment and management of chronic wounds.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Healthcare Analytics, Medical Imaging

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS, Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

chronic wound assessmentwound care AIdigital wound managementdiagnostic medical devicecomputer visionmulti-spectral scannerclinical decision supportmedtechhealthtech3D wound measurementremote patient monitoringtelehealthtemperature screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KroniKare Comparables

Compare KroniKare with similar companies based on industry and business-model similarity.

KroniKare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Swift Medical
85%
Rubitection
85%
cureVision
84%

KroniKare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 6, 2020
AcceleratorJul 18, 2019
SeedMay 31, 2018
AcceleratorMar 21, 2017

KroniKare Investors

Notable investors and investment history

KroniKare investors
InvestorRounds
AngelCentralSeries A
Essex Bio-TechnologySeries A
Anthill VenturesSeries A, Accelerator
SparkLabs Global VenturesSeed
Entrepreneurs FirstAccelerator
SGInnovateSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 6, 2020

    $1.3M round with participation from Anthill Ventures and AngelCentral.

  • Jul 18, 2019

    Led by Anthill Ventures with participation from Healthcare Global Enterprises.

KroniKare Filings

Explore SEC and related filing metadata, where available.

KroniKare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about KroniKare's valuation, stock price, and market status.

Is KroniKare a public or private company?

KroniKare is a private company.

What is the current stock price of KroniKare?

KroniKare is a private company with no public stock price. No recent secondary market data is available.

How much is KroniKare worth (valuation)?

KroniKare's valuation is estimated at $5.2M based on funding round data.

Can I buy KroniKare stock?

KroniKare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was KroniKare's last funding round?

KroniKare's most recent funding round was Series A on October 6, 2020.

Who are the main investors in KroniKare?

Key investors in KroniKare include Anthill Ventures, Entrepreneurs First.

Will KroniKare IPO soon?

No public IPO plans have been announced for KroniKare.

How can I track KroniKare secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KroniKare's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Year Founded2017
Last FundingOct 6, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?